TPMT and acute lymphoblastic leukemia: In Indian paediatric ALL cohorts, NUDT15 c.415C>T has been reported in approximately 9%–10.7% of cases, while TPMT*3C appears in 3%–3.5% (Pratt et al., 2022; Relling et al., 2019).